The long-acting anti-C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab.
Br J Haematol
; 201(1): e1-e4, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36660816
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Erythrocytes
/
Hemoglobinuria, Paroxysmal
Limits:
Humans
Language:
En
Journal:
Br J Haematol
Year:
2023
Type:
Article
Affiliation country:
Italy